Back to User profile » Dr Haiyan Zhu
Papers published by Dr Haiyan Zhu:
Emerging Therapeutic Strategies of Different Immunotherapy Approaches Combined with PD-1/PD-L1 Blockade in Cervical Cancer
Ge Y, Zhang Y, Zhao KN, Zhu H
Drug Design, Development and Therapy 2022, 16:3055-3070
Published Date: 9 September 2022
The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer
Jiang Q, Wang L, Jin M, Shou Y, Zhu H, Li A
International Journal of General Medicine 2022, 15:3903-3914
Published Date: 11 April 2022
Oncogenic Role of NUPR1 in Ovarian Cancer
Yu J, Zhu H, Li R, Jiang Q, Luan W, Shi J, Liu P
OncoTargets and Therapy 2020, 13:12289-12300
Published Date: 30 November 2020
Risk Stratification Based on Metastatic Pelvic Lymph Node Status in Stage IIIC1p Cervical Cancer
Li A, Wang L, Jiang Q, Wu W, Huang B, Zhu H
Cancer Management and Research 2020, 12:6431-6439
Published Date: 28 July 2020
Characteristics and Treatments of Patients Aged 65 Years or Over with Cervical Cancer
Xie S, Pan S, Zou S, Zhu H, Zhu X
Clinical Interventions in Aging 2020, 15:841-851
Published Date: 3 June 2020
Efficacy And Safety Of Apatinib Treatment In Platinum-Resistant Recurrent Epithelial Ovarian Cancer: A Real World Study
Zhang J, Li A, Jiang Q, Zheng F, Zhu H
Drug Design, Development and Therapy 2019, 13:3913-3918
Published Date: 15 November 2019
The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study
Yu J, Xu Z, Li A, Zhang J, Wang Y, Zhao H, Zhu H
Drug Design, Development and Therapy 2019, 13:3419-3424
Published Date: 26 September 2019
Molecular mechanisms of cisplatin resistance in cervical cancer
Zhu H, Luo H, Zhang W, Shen Z, Hu X, Zhu X
Drug Design, Development and Therapy 2016, 10:1885-1895
Published Date: 7 June 2016